Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 87, Issue 4, Pages 1563-1568Publisher
ENDOCRINE SOC
DOI: 10.1210/jc.87.4.1563
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL-03804] Funding Source: Medline
- NICHD NIH HHS [HD-39223] Funding Source: Medline
Ask authors/readers for more resources
Insulin resistance is implicated in the pathogenesis of pre-eclampsia, but prospective data are limited. SHBG, a marker of insulin resistance among nonpregnant individuals, has not been studied in detail during pregnancy. We conducted a prospective, nested, case-control study to test the hypothesis that increased insulin resistance, marked by reduced first trimester SHBG levels, is associated with increased risk of subsequent preeclampsia. First trimester SHBG levels were measured in 45 nulliparous women who subsequently developed preeclampsia (blood pressure, greater than or equal to140/90 mm Hg; proteinuria, either greater than or equal to2+ by dipstick or greater than or equal to300 mg/24 h, after 20 wk gestation) and in 90 randomly selected normotensive nulliparous controls. Compared with controls, women who developed preeclampsia had significantly reduced first trimester SHBG levels (302 +/- 130 vs. 396 +/- 186 nmol/liter; P < 0.01). Every 100 nmol/liter increase in SHBG was associated with a 31% reduced risk of preeclampsia [odds ratio (OR), 0.69; 95% confidence interval (CI), 0.55, 0.88; P < 0.011. After adjusting for covariates in a multiple logistic regression model, the association between first trimester SHBG and preeclampsia remained significant (per 100 nmol/liter increase; OR, 0.66; 95% Cl, 0.47, 0.92; P = 0.01). When subjects were stratified by body mass index (lean: body mass index, <25 kg/m(2); overweight: body mass index, >= 25 kg(m(2)), overweight women had lower SHBG levels than lean women (286 +/- 156 vs. 410 +/- 166 nmol/ liter; P < 0.01), and within each stratum, women with pre-eclampsia had lower SEEG levels than their respective controls. In a multivariable analysis, the association between SHBG and preeclampsia strengthened among lean women, such that every 100 nmol/liter increase in serum SHBG was associated with a 55% reduction in the risk of preeclampsia (OR, 0.45; 95% CI, 0.27, 0.77; P < 0.01), whereas in overweight women, the association was mitigated (OR, 1.02; 95% Cl, 0.62, 1.69; P = 0.9). We conclude that increased early pregnancy insulin resistance is independently associated with subsequent preeclampsia. First trimester SHBG levels may be a useful biomarker for preeclampsia, especially among lean women who otherwise would be perceived to be at low risk.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available